| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli M Di Nicola, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, ... Blood, The Journal of the American Society of Hematology 99 (10), 3838-3843, 2002 | 4354 | 2002 |
| Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4, 5-bisphosphate hydrolysis in LtK-fibroblasts … L Vallar, C Muca, M Magni, P Albert, J Bunzow, J Meldolesi, O Civelli Journal of Biological Chemistry 265 (18), 10320-10326, 1990 | 313 | 1990 |
| Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer M Magni, S Shammah, R Schiro, W Mellado, R Dalla-Favera, AM Gianni | 312 | 1996 |
| Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion M Magni, M Di Nicola, L Devizzi, P Matteucci, F Lombardi, L Gandola, ... Blood, The Journal of the American Society of Hematology 96 (3), 864-869, 2000 | 306 | 2000 |
| Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) AM Gianni, M Magni, M Martelli, M Di Nicola, C Carlo-Stella, S Pilotti, ... Blood 102 (2), 749-755, 2003 | 289 | 2003 |
| Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ... Clinical Cancer Research 15 (13), 4415-4422, 2009 | 254 | 2009 |
| Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in … C Tarella, R Passera, M Magni, F Benedetti, A Rossi, A Gueli, C Patti, ... Journal of Clinical Oncology 29 (7), 814-824, 2011 | 176 | 2011 |
| Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer M Bregni, M Magni, S Siena, M Di Nicola, G Bonadonna, AM Gianni Blood 80 (6), 1418-1422, 1992 | 162 | 1992 |
| Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a … M Di Nicola, R Zappasodi, C Carlo-Stella, R Mortarini, SM Pupa, M Magni, ... Blood, The Journal of the American Society of Hematology 113 (1), 18-27, 2009 | 154 | 2009 |
| Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death R Zappasodi, SM Pupa, GC Ghedini, I Bongarzone, M Magni, AD Cabras, ... Cancer research 70 (22), 9062-9072, 2010 | 151 | 2010 |
| The effect of epidermal growth factor on membrane potential: rapid hyperpolarization followed by persistent fluctuations A Pandiella, M Magni, D Lovisolo, J Meldolesi Journal of Biological Chemistry 264 (22), 12914-12921, 1989 | 111 | 1989 |
| Ionic events induced by epidermal growth factor. Evidence that hyperpolarization and stimulated cation influx play a role in the stimulation of cell growth. M Magni, J Meldolesi, A Pandiella Journal of Biological Chemistry 266 (10), 6329-6335, 1991 | 101 | 1991 |
| Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple … C Tarella, M Zanni, M Di Nicola, C Patti, R Calvi, A Pescarollo, V Zoli, ... Leukemia 21 (8), 1802-1811, 2007 | 98 | 2007 |
| Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination: A Phase I Trial in Metastatic Melanoma M Di Nicola, C Carlo-Stella, R Mortarini, P Baldassari, A Guidetti, ... Clinical cancer research 10 (16), 5381-5390, 2004 | 93 | 2004 |
| Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie … C Tarella, M Zanni, M Magni, F Benedetti, C Patti, T Barbui, A Pileri, ... Journal of Clinical Oncology 26 (19), 3166-3175, 2008 | 92 | 2008 |
| High-dose yttrium-90–ibritumomab tiuxetan with tandem stem-cell reinfusion: An outpatient preparative regimen for autologous hematopoietic cell transplantation L Devizzi, A Guidetti, C Tarella, M Magni, P Matteucci, E Seregni, ... Journal of clinical oncology 26 (32), 5175-5182, 2008 | 88 | 2008 |
| High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease—a 6-year update AM Gianni, S Siena, M Bregni, F Lombardi, L Gandola, M Di Nicola, ... Annals of oncology 4 (10), 889-891, 1993 | 83 | 1993 |
| Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors. M Di Nicola, S Siena, M Bregni, P Longoni, M Magni, M Milanesi, ... Cancer Gene Therapy 5 (6), 350-356, 1998 | 79 | 1998 |
| Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma M Ladetto, M Magni, G Pagliano, F De Marco, D Drandi, I Ricca, M Astolfi, ... Biology of Blood and Marrow Transplantation 12 (12), 1270-1276, 2006 | 72 | 2006 |
| Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene L Gandino, L Munaron, L Naldini, R Ferracini, M Magni, PM Comoglio Journal of Biological Chemistry 266 (24), 16098-16104, 1991 | 72 | 1991 |
